Multispecific Chimeric Antigen Receptors Patent EP4182356A1
Summary
The EPO published European Patent Application EP4182356A1 for multispecific chimeric antigen receptors (CARs) and uses thereof, filed by Legend Biotech Ireland Limited and Legend Biotech USA Inc. The patent application names FAN Xiaohu, ZHOU Zhe, and PAN Hongbo as inventors, and covers compositions and methods for cancer treatment. The application is classified under eight IPC codes spanning hybrid proteins, T-cell receptors, antibodies, and therapeutic applications. Designated states include thirty-two European countries and territories including AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, and TR.
About this source
GovPing monitors EPO Patent Bulletin - Peptides (C07K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 58 changes logged to date.
What changed
The EPO published European Patent Application EP4182356A1 for multispecific chimeric antigen receptors and uses thereof. The patent application was filed by Legend Biotech Ireland Limited and Legend Biotech USA Inc., with inventors FAN Xiaohu, ZHOU Zhe, and PAN Hongbo. The application covers eight IPC classifications related to hybrid proteins, T-cell receptors, antibody constructs, and cancer therapeutics.
Affected parties seeking to develop, license, or commercialize multispecific CAR technologies for cancer applications in European markets should review this patent publication to assess potential freedom-to-operate considerations. Applicants for similar technologies in designated states should evaluate potential overlap with the claims disclosed in this application.
Archived snapshot
Apr 25, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
MULTISPECIFIC CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
Publication EP4182356A1 Kind: A1 Apr 15, 2026
Applicants
Legend Biotech Ireland Limited, Legend Biotech USA Inc.
Inventors
FAN, Xiaohu, ZHOU, Zhe, PAN, Hongbo
IPC Classifications
C07K 19/00 20060101AFI20241017BHEP C07K 14/725 20060101ALI20241017BHEP C07K 16/28 20060101ALI20241017BHEP C07K 16/30 20060101ALI20241017BHEP C12N 15/62 20060101ALI20241017BHEP C12N 15/63 20060101ALI20241017BHEP C12N 5/10 20060101ALI20241017BHEP A61P 35/00 20060101ALI20241017BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.